about
Activating mutations in RRAS underlie a phenotype within the RASopathy spectrum and contribute to leukaemogenesisMolecular biology of lung cancer: clinical implicationsHistological Stains: A Literature Review and Case StudyMolecular pathology - the value of an integrative approachMolecular pathology of lung cancer: key to personalized medicine.The possibility of clinical sequencing in the management of cancerMolecular pathological epidemiology in diabetes mellitus and risk of hepatocellular carcinomaPulmonary adenocarcinoma: a renewed entity in 2011Lauriston S. Taylor Lecture on radiation protection and measurements: what makes particle radiation so effective?Specific and sensitive hydrolysis probe-based real-time PCR detection of epidermal growth factor receptor variant III in oral squamous cell carcinomaTherapeutic advances for the tumors associated with neurofibromatosis type 1, type 2, and schwannomatosisCellular heterogeneity and live cell arrays.Therapeutically activating RB: reestablishing cell cycle control in endocrine therapy-resistant breast cancer.K-Ras mediated murine epidermal tumorigenesis is dependent upon and associated with elevated Rac1 activityA conceptual and methodological framework for investigating etiologic heterogeneityInstability of the octarepeat region of the human prion protein gene.A DNA methylation fingerprint of 1628 human samples.Next-generation sequencing for cancer diagnostics: a practical perspective.EGFR and K-Ras mutations in women with lung adenocarcinoma: implications for treatment strategy definition.Survivin selectively modulates genes deregulated in human leukemia stem cells.A strategy for distinguishing optimal cancer subtypes.Genomic investigation of etiologic heterogeneity: methodologic challengesIn vivo molecular mapping of the tumor microenvironment in an azoxymethane-treated mouse model of colon carcinogenesis.An Update on the Biology of RAS/RAF Mutations in Colorectal Cancer.Epigenetics and genetics. MicroRNAs en route to the clinic: progress in validating and targeting microRNAs for cancer therapy.Vitamin D receptor Cdx-2 polymorphism and premenopausal breast cancer risk in southern Pakistani patientsMaintenance of glia in the optic lamina is mediated by EGFR signaling by photoreceptors in adult Drosophila.An emerging toolkit for targeted cancer therapies.KEAP1 gene mutations and NRF2 activation are common in pulmonary papillary adenocarcinoma.An update on miRNAs as biological and clinical determinants in colorectal cancer: a bench-to-bedside approach.Identifying Etiologically Distinct Sub-Types of Cancer: A Demonstration Project Involving Breast CancerIn situ biomarker discovery and label-free molecular histopathological diagnosis of lung cancer by ambient mass spectrometry imaging.Active learning framework with iterative clustering for bioimage classification.Gene set enrichment analysis unveils the mechanism for the phosphodiesterase 4B control of glucocorticoid response in B-cell lymphoma.Challenges in identifying candidate amplification targets in human cancers: chromosome 8q21 as a case study.Mitogen-activated protein kinase phosphatase (MKP)-1 in immunology, physiology, and disease.Correlation between Gene Variants, Signaling Pathways, and Efficacy of Chemotherapy Drugs against Colon CancersThe PKCθ pathway participates in the aberrant accumulation of Fra-1 protein in invasive ER-negative breast cancer cells.Oncogenic RAS pathway activation promotes resistance to anti-VEGF therapy through G-CSF-induced neutrophil recruitment.Incremental costs of prostate cancer trials: Are clinical trials really a burden on a public payer system?
P2860
Q24294030-56C0916C-2F71-4EFC-95A1-B3F0227EE406Q24610335-2AAD0BE2-D41D-4D6B-B0C2-528C06C01022Q26780340-11583A0A-845F-4EC9-AA38-072BD0436946Q27023628-F0A9C629-D29C-4FB5-A2E0-B4A73E92E66BQ27691299-B2E4116B-1A36-434D-AAE2-F5B7D07AC195Q28072144-CABD96CD-D1E6-4185-B42C-4C1C83785ACAQ28076106-CCA81AF7-7608-4FFC-B576-44805A6B59A7Q28395348-C493177E-9DF5-42E8-9FF4-D309D6FC8795Q28710510-779C64AC-4BF5-49CE-8C34-4BC70CD2B555Q28732052-26CFDD90-CDFD-42D6-AD3A-C51942F66AFCQ30357776-8A2133F8-C5F9-4AB9-9827-129D409EA177Q30401785-56BE3F67-BD26-4369-8938-6C6C4A52DEC2Q30419997-98C88E67-0990-4B30-AF79-D063B80858A9Q33831720-8E0F6081-61FC-4207-B9B2-D50D802A38C4Q33923726-39B9F883-BC56-4089-B124-055CA26A7860Q34058767-8D783C91-F721-494A-B9FA-C7A47CDF4DEDQ34187360-38963E43-8109-4F21-A234-19D70FC634FAQ34238930-31C5FCE9-9CFB-457C-8257-C543F6E7654FQ34346624-2438ACF1-D097-47F2-B01A-49774809A463Q34495409-03C2F522-5756-4792-9F8D-4631D8B4EF16Q34594334-CADA588E-C6A0-416C-8703-5634791F2718Q34937805-62DFACE9-D3C0-4904-8253-BD2C28BFE7A4Q35007556-D18701DD-0155-49B3-9847-17BF6CB81023Q35010156-F5E20AEB-04AD-4328-B7EC-2BB05EF7AE31Q35039281-11C964D4-0036-4E16-8244-64C80349792EQ35208354-3FC11027-46D6-4BF3-9A76-7D2F9130F6CDQ35536431-BBB3F2A1-C7CF-4B83-9451-C909D75DFC44Q35694357-506FBF2D-A8F5-4187-B1E6-159B9B8287D7Q35711633-16AD055E-49DC-44CF-A699-C6BC3F42CD4CQ35811250-7DEB0093-9CE2-408D-932F-DECD393A6443Q36051807-ACCBBCDF-CD43-4B8A-839E-5CB0C1E01258Q36099880-3F99C314-0224-4F62-BE46-42EE4B9263C1Q36204281-CE5E65B9-CFBD-4F1B-AA49-6041BD420244Q36295294-872FA9E6-4750-46A0-9B8B-CE7204A2B494Q36296457-F0FA3A71-04C2-452F-A2D1-6FCA17CE1908Q36301783-1741718E-17F2-41D4-BD4E-DD96C2954370Q36487348-6815203E-90D4-436A-871C-43B6BB7E04F7Q36760840-646F1FDA-8869-4261-8096-081ECF9EF04FQ36762385-D5CBAC49-524C-4515-B69B-1B364E63F99CQ36833759-BA603A86-41E0-4136-A8E2-A2CA7E3859C4
P2860
description
2010 nî lūn-bûn
@nan
2010 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
The molecular pathology of cancer
@ast
The molecular pathology of cancer
@en
The molecular pathology of cancer
@nl
type
label
The molecular pathology of cancer
@ast
The molecular pathology of cancer
@en
The molecular pathology of cancer
@nl
prefLabel
The molecular pathology of cancer
@ast
The molecular pathology of cancer
@en
The molecular pathology of cancer
@nl
P3181
P1476
The molecular pathology of cancer
@en
P2093
Frank McCormick
Timothy J R Harris
P304
P3181
P356
10.1038/NRCLINONC.2010.41
P407
P577
2010-05-01T00:00:00Z